Mark Lanier founded The Lanier Law Firm in 1990, and has earned widespread recognition as one of the nation’s top trial lawyers. So much so that The New York Times described him as “one of the top civil trial lawyers in America.”
In 2018, Mr. Lanier secured a $4.69 billion jury verdict on behalf of 22 women and their families who alleged that decades of daily use of Johnson & Johnson’s talcum powder products caused their ovarian cancer. In recent years Mr. Lanier secured three jury verdicts in trials alleging serious medical complications caused by hip implants made by Johnson & Johnson and its subsidiary, DePuy. Collectively the verdicts in those cases totaled more than $1.75 billion.
Known for his intense trial preparation and engaging style with juries, Mr. Lanier is also recognized for his win in the first case tried to verdict involving the medication VIOXX, and the courtroom victory against Takeda Pharmaceutical and Eli Lilly over the diabetes drug Actos. Mr. Lanier also has significant experience representing businesses in cases involving in a range of commercial disputes, particularly actions against companies using unfair and unlawful business practices to gain a competitive edge.
Cumulatively, Mr. Lanier has garnered almost $20 billion in verdicts during his highly acclaimed career. Among his numerous accolades, Mark has been listed in U.S. News and World Report’s Best Lawyers in America list from 2006 – 2020, including previously being named the 2013 Top Class Action Attorney in America.
Mr. Lanier earned his law degree from Texas Tech University School of Law in 1984. He remains active at the university by serving on the Law School's Foundation Board. Mr. Lanier was selected as the Texas Tech University School of Law Distinguished Alumnus for 2005.